These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1861460)

  • 21. Autoimmune thyroiditis in a case of tyrosinaemia type III.
    D'Eufemia P; Giardini O; Cantani A; Martino F; Finocchiaro R
    J Inherit Metab Dis; 1992; 15(6):861-2. PubMed ID: 1293381
    [No Abstract]   [Full Text] [Related]  

  • 22. Coagulation defect of congenital tyrosinaemia.
    Evans DI; Sardharwalla IB
    Arch Dis Child; 1984 Nov; 59(11):1088-90. PubMed ID: 6508343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.
    van Spronsen FJ; Berger R; Smit GP; de Klerk JB; Duran M; Bijleveld CM; van Faassen H; Slooff MJ; Heymans HS
    J Inherit Metab Dis; 1989; 12 Suppl 2():339-42. PubMed ID: 2556611
    [No Abstract]   [Full Text] [Related]  

  • 24. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B; Lindstedt S; Steen G
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enzyme defects in hereditary tyrosinaemia type I.
    Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
    J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
    [No Abstract]   [Full Text] [Related]  

  • 26. The kidney in children with tyrosinemia: sonographic, CT and biochemical findings.
    Forget S; Patriquin HB; Dubois J; Lafortune M; Merouani A; Paradis K; Russo P
    Pediatr Radiol; 1999 Feb; 29(2):104-8. PubMed ID: 9933329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosinaemia--treatment and outcome.
    Kvittingen EA
    J Inherit Metab Dis; 1995; 18(4):375-9. PubMed ID: 7494396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.
    Tuchman M; Freese DK; Sharp HL; Whitley CB; Ramnaraine ML; Ulstrom RA; Najarian JS; Ascher N; Buist NR; Terry AB
    J Inherit Metab Dis; 1985; 8(1):21-4. PubMed ID: 2581063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation in nine Spanish patients with tyrosinaemia type I.
    Pérez-Cerdá C; Merinero B; Sanz P; Castro M; Gangoiti J; García MJ; Díaz M; Medina E; Ugarte M
    J Inherit Metab Dis; 1995; 18(2):119-22. PubMed ID: 7564224
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenatal diagnosis of hereditary tyrosinaemia type I by determination of fumarylacetoacetase in chorionic villus material.
    Kvittingen EA; Guibaud PP; Divry P; Mandon G; Rolland MO; Domenichini Y; Jakobs C; Christensen E
    Eur J Pediatr; 1986 Apr; 144(6):597-8. PubMed ID: 3709578
    [No Abstract]   [Full Text] [Related]  

  • 31. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
    Endo F; Katoh H; Matsuda I
    J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
    [No Abstract]   [Full Text] [Related]  

  • 32. Visceral pathology of hereditary tyrosinemia type I.
    Russo P; O'Regan S
    Am J Hum Genet; 1990 Aug; 47(2):317-24. PubMed ID: 2378357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
    Paige DG; Clayton P; Bowron A; Harper JI
    J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
    [No Abstract]   [Full Text] [Related]  

  • 34. Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients.
    Dubois J; Garel L; Patriquin H; Paradis K; Forget S; Filiatrault D; Grignon A; Russo P; St-Vil D
    Pediatr Radiol; 1996 Dec; 26(12):845-51. PubMed ID: 8929295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

  • 36. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary tyrosinaemia (HT) type 1A.
    Lam AH; Villanueva AC; Ong J
    Australas Radiol; 1993 Feb; 37(1):60-2. PubMed ID: 8323513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of methylmalonic acidaemia by combined liver-kidney transplantation.
    Nagarajan S; Enns GM; Millan MT; Winter S; Sarwal MM
    J Inherit Metab Dis; 2005; 28(4):517-24. PubMed ID: 15902554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.
    Bain MD; Purkiss P; Jones M; Bingham P; Stacey TE; Chalmers RA
    Eur J Pediatr; 1990 Jun; 149(9):637-9. PubMed ID: 2373116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
    Kvittingen EA; Leonard JV; Pettit BR; King GS
    Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.